These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 16585179

  • 1. Constitutive activation of extracellular signal-regulated kinase predisposes diffuse large B-cell lymphoma cell lines to CD40-mediated cell death.
    Hollmann CA, Owens T, Nalbantoglu J, Hudson TJ, Sladek R.
    Cancer Res; 2006 Apr 01; 66(7):3550-7. PubMed ID: 16585179
    [Abstract] [Full Text] [Related]

  • 2. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line.
    Padmore L, An S, Gunby RH, Kelly K, Radda GK, Knox KA.
    Cell Immunol; 1997 May 01; 177(2):119-28. PubMed ID: 9178638
    [Abstract] [Full Text] [Related]

  • 3. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
    Walker A, Taylor ST, Hickman JA, Dive C.
    Cancer Res; 1997 May 15; 57(10):1939-45. PubMed ID: 9157989
    [Abstract] [Full Text] [Related]

  • 4. Vav-1 expression correlates with NFκB activation and CD40-mediated cell death in diffuse large B-cell lymphoma cell lines.
    Hollmann A, Aloyz R, Baker K, Dirnhofer S, Owens T, Sladek R, Tzankov A.
    Hematol Oncol; 2010 Sep 15; 28(3):142-50. PubMed ID: 20155735
    [Abstract] [Full Text] [Related]

  • 5. Superantigen-induced corticosteroid resistance of human T cells occurs through activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK-ERK) pathway.
    Li LB, Goleva E, Hall CF, Ou LS, Leung DY.
    J Allergy Clin Immunol; 2004 Nov 15; 114(5):1059-69. PubMed ID: 15536411
    [Abstract] [Full Text] [Related]

  • 6. The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.
    Paterson JC, Tedoldi S, Craxton A, Jones M, Hansmann ML, Collins G, Roberton H, Natkunam Y, Pileri S, Campo E, Clark EA, Mason DY, Marafioti T.
    Haematologica; 2006 Jun 15; 91(6):772-80. PubMed ID: 16769579
    [Abstract] [Full Text] [Related]

  • 7. CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphoma.
    Burington B, Yue P, Shi X, Advani R, Lau JT, Tan J, Stinson S, Stinson J, Januario T, de Vos S, Ansell S, Forero-Torres A, Fedorowicz G, Yang TT, Elkins K, Du C, Mohan S, Yu N, Modrusan Z, Seshagiri S, Yu SF, Pandita A, Koeppen H, French D, Polson AG, Offringa R, Whiting N, Ebens A, Dornan D.
    Sci Transl Med; 2011 Mar 16; 3(74):74ra22. PubMed ID: 21411738
    [Abstract] [Full Text] [Related]

  • 8. Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40.
    Law CL, Gordon KA, Collier J, Klussman K, McEarchern JA, Cerveny CG, Mixan BJ, Lee WP, Lin Z, Valdez P, Wahl AF, Grewal IS.
    Cancer Res; 2005 Sep 15; 65(18):8331-8. PubMed ID: 16166310
    [Abstract] [Full Text] [Related]

  • 9. Increase in Bcl-2 level promoted by CD40 ligation correlates with inhibition of B cell apoptosis induced by vacuolar type H(+)-ATPase inhibitor.
    Akifusa S, Ohguchi M, Koseki T, Nara K, Semba I, Yamato K, Okahashi N, Merino R, Núñez G, Hanada N, Takehara T, Nishihara T.
    Exp Cell Res; 1998 Jan 10; 238(1):82-9. PubMed ID: 9457059
    [Abstract] [Full Text] [Related]

  • 10. CD40 and B-cell receptor signalling induce MAPK family members that can either induce or repress Bcl-6 expression.
    Batlle A, Papadopoulou V, Gomes AR, Willimott S, Melo JV, Naresh K, Lam EW, Wagner SD.
    Mol Immunol; 2009 May 10; 46(8-9):1727-35. PubMed ID: 19268365
    [Abstract] [Full Text] [Related]

  • 11. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT, Klein PJ, Wentz SC, Zeni A, Menze A, Schmidt CM.
    J Pharmacol Exp Ther; 2009 Jun 10; 329(3):1063-70. PubMed ID: 19258520
    [Abstract] [Full Text] [Related]

  • 12. La(3+)-induced extracellular signal-regulated kinase (ERK) signaling via a metal-sensing mechanism linking proliferation and apoptosis in NIH 3T3 cells.
    Yu S, Hu J, Yang X, Wang K, Qian ZM.
    Biochemistry; 2006 Sep 19; 45(37):11217-25. PubMed ID: 16964983
    [Abstract] [Full Text] [Related]

  • 13. Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells.
    Ma Y, Yu WD, Kong RX, Trump DL, Johnson CS.
    Cancer Res; 2006 Aug 15; 66(16):8131-8. PubMed ID: 16912191
    [Abstract] [Full Text] [Related]

  • 14. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R, Piperdi S, Gorlick R.
    Clin Cancer Res; 2008 Oct 15; 14(20):6396-404. PubMed ID: 18927278
    [Abstract] [Full Text] [Related]

  • 15. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells.
    Yu W, Shun MC, Anderson K, Chen H, Sanders BG, Kline K.
    Apoptosis; 2006 Oct 15; 11(10):1813-23. PubMed ID: 16850165
    [Abstract] [Full Text] [Related]

  • 16. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.
    Chetoui N, Sylla K, Gagnon-Houde JV, Alcaide-Loridan C, Charron D, Al-Daccak R, Aoudjit F.
    Mol Cancer Res; 2008 Jan 15; 6(1):42-52. PubMed ID: 18234961
    [Abstract] [Full Text] [Related]

  • 17. Targeting beta2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma.
    Nomura T, Huang WC, Seo S, Zhau HE, Mimata H, Chung LW.
    J Urol; 2007 Jul 15; 178(1):292-300. PubMed ID: 17499801
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of the ERK pathway promotes apoptosis induced by 2-chloro-2'-deoxyadenosine in the B-cell leukemia cell line EHEB.
    Smal C, Lisart S, Ferrant A, Bontemps F, van den Neste E.
    Nucleosides Nucleotides Nucleic Acids; 2006 Jul 15; 25(9-11):1009-12. PubMed ID: 17065055
    [Abstract] [Full Text] [Related]

  • 19. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
    Takahashi H, Feuerhake F, Kutok JL, Monti S, Dal Cin P, Neuberg D, Aster JC, Shipp MA.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3265-71. PubMed ID: 16740746
    [Abstract] [Full Text] [Related]

  • 20. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
    Ulivi P, Arienti C, Amadori D, Fabbri F, Carloni S, Tesei A, Vannini I, Silvestrini R, Zoli W.
    J Cell Physiol; 2009 Jul 01; 220(1):214-21. PubMed ID: 19288493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.